Perrigo Nets Former Pharmacia Counsel Kingma To Support New Strategy
This article was originally published in The Tan Sheet
Perrigo's appointment of former Pharmacia associate general counsel Todd Kingma to VP and general counsel reflects the firm's recent expansion into generic Rx pharmaceuticals and bolsters its OTC patent defense team
You may also be interested in...
Perrigo expects to meet its fiscal 2004 target for core business growth despite continued delays in the approval of its 10 mg loratadine tablets (Schering-Plough's Claritin)
Perrigo's planned introduction of two generic loratadine formulations in early 2004 is expected to improve the firm's lackluster cough/cold sales in the second half of its fiscal year
Perrigo plans to complement its OTC pharmaceutical drug business with a foray into generic prescription drugs next year